Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Dow
McKinsey
Cantor Fitzgerald
Chubb
Express Scripts
QuintilesIMS
Deloitte
Harvard Business School

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040733

« Back to Dashboard

NDA 040733 describes DIPYRIDAMOLE, which is a drug marketed by Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Barr, Glenmark Generics, Idt Australia Ltd, Impax Labs, Lannett, Murty Pharms, Oxford Pharms, Purepac Pharm, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. It is available from nine suppliers. Additional details are available on the DIPYRIDAMOLE profile page.

The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Summary for 040733
Tradename:DIPYRIDAMOLE
Applicant:Murty Pharms
Ingredient:dipyridamole
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Pharmacology for NDA: 040733
Physiological EffectDecreased Platelet Aggregation
Medical Subject Heading (MeSH) Categories for 040733
Suppliers and Packaging for NDA: 040733
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIPYRIDAMOLE dipyridamole TABLET;ORAL 040733 ANDA Rising Pharmaceuticals, Inc. 64980-133 N 64980-133-01
DIPYRIDAMOLE dipyridamole TABLET;ORAL 040733 ANDA Rising Pharmaceuticals, Inc. 64980-133 N 64980-133-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Feb 13, 2007TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Feb 13, 2007TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength75MG
Approval Date:Feb 13, 2007TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Johnson and Johnson
Boehringer Ingelheim
Chinese Patent Office
Medtronic
Chubb
Daiichi Sankyo
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.